To see all protocols that comply with the WHO Essential Medicine List 

The World Health Organisation (WHO) 2016 classification of tumours of the central nervous system includes both histological features and molecular classification.rr Using and extrapolating evidence published prior to this update needs to take into account that tumours were defined histologically. 

The information contained in this protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to treatment. Any clinician (medical oncologist, haematologist, radiation oncologist, medical physicist, radiation therapist, pharmacist or nurse) seeking to apply or consult this protocol is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

10 Jul 2020